Skip to content
Home/Companies/Biotech/Orbis Medicines

Orbis Medicines

Biotech·Denmark·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Orbis Medicines?

Orbis Medicines is currently owned by Novo Holdings through Novo Holdings Seed Investments (1999 vintage), since 2024. Across its history, Orbis Medicines has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-08-18

Novo Holdings
Most recent investor
Novo Holdings
Novo Holdings Seed Investments · 1999 · VC
2 ownership periods · full history below

Key facts

HQDenmark
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Novo Holdings and Eifo since 2024.
Co-invest · 2 holders · 2024 · present
Novo Holdings
2024 · present(2yr) · Novo Holdings Seed Investments · 1999 · VC
Eifo
EifoActive
2025 · present(1yr) · EIFO (direct equity) · 1992 · VC
Track Orbis Medicines

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Orbis Medicines?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Orbis Medicines.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue